Research & Development: Page 34

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Using Electric Fields to Treat Cancer Bill Doyle, Executive Chairman of Novocure, talks about the company’s treatment that uses electric fields to treat glioblastoma, a deadly brain cancer, and other cancers. Novocure’s approach to treating cancer may look like pseudo science, but the results are...

    By Bill Doyle • Oct. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Pharma’s Role in the Community John Damonti, President of the Bristol-Myers Squibb Foundation and VP of Corporate Philanthropy at Bristol-Myers Squibb, talks about how his company and other pharmaceutical companies can provide relief during disasters, such as Hurricanes Harvey and Irma. PV: Why d...

    By John Damonti • Oct. 1, 2017
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A Connected Healthcare Life

    Three years ago, Verily — then a division of Google X — unveiled its Baseline Project, a collaboration with Duke University and Stanford University to collect health data from healthy people to get a sense of what “normal" looks like. Earlier this year, the group began the process of enrolling 10...

    By Robin Robinson • Oct. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Solutions for Clinical Sites

    Clinical study sites are transforming their technology infrastructures with the adoption of electronic medical records (EMRs). But while EMRs improve treatment-related tasks in healthcare settings, they have not helped to reduce the burden of clinical trial studies on the sites. A May 2017 survey...

    By Denise Myshko • Oct. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Upfront

    Bayer and the White Ribbon Alliance The partnership of Bayer and the White Ribbon Alliance (WRA), Every Woman Every Child, has reached 1,200 women in 91 communities across four developing countries. The partnership’s goal has been to launch local community programs to support the reduction and pr...

    By PharmaVoice Team • Sept. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    New Exhaled Breath Sensor Spots Diseases, Monitors Health Trend Watch: The application of very small things to yield very big health results A study published in the Accounts of Chemical Research journal reports that Korea Advanced Institute of Science and Technology’s researchers have developed ...

    By PharmaVoice Team • Sept. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    A New Option for PAH Preston Klassen, M.D., Executive VP, Research and Development and Chief Medical Officer, Arena Pharmaceuticals, talks about the company’s efforts to develop a new therapy for pulmonary hypertension. Pulmonary arterial hypertension (PAH) is a rare disease that affects the hear...

    By Preston Klassen • Sept. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Speak Out

    TREATING THE WHOLE PATIENT: A More Compelling Approach to Product Development Instead of focusing only on your product, consider the impact if your product was studied in tandem with an intervention that addresses whole patient needs. By taking this approach, you’re formulating a plan to differen...

    By Mark Matthews • Sept. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Storied Careers This is my favorite issue of the year — nothing against the other great issues we put out every month. But there is something particularly special about showcasing 100 men and women who have dedicated their lives to the life-sciences industry. They could be using their talents in ...

    By Taren Grom • Aug. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Who's On The List by Section

    This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured. Change Agents Danielle Bedard inVentiv Health Kathy Biberstein Alkermes Kim Carpenter HCB Health Dr. Ryan Cohlhepp Takeda Oncology Su...

    By PharmaVoice Team • Aug. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Clinical Experts

    Mark Penniston The Curious Pragmatist Title: Executive VP and General Manager, Clinical Analytics & Source Company: Chiltern Education: BS, MS, University of Massachusetts Family: Wife, Melissa Hobbies: Reading, traveling to National Parks & Disney Social Media: In this biotech environmen...

    By PharmaVoice Team • Aug. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Innovators

    Dr. Bill Byrom At the Forefront of eClinical Technology Title: Senior Director of Product Innovation Company: ICON Clinical Research Education: BSc, Mathematics with Statistics, University of Nottingham; PhD, University of Strathclyde Family: Wife, Tina; two teenage daughters, Charlotte and Sophi...

    By PharmaVoice Team • Aug. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Patient Advocates

    Nikki Levy Caring Connections Title: VP, Patient Engagement Company: Alkermes Inc. Education: BS, Communications, Illinois State University Family: As a child of a single mom she learned to be fiercely independent, internally motivated and to value hard work Hobbies: Running, reading, traveling A...

    By PharmaVoice Team • Aug. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Researchers & Scientists

    Dr. Daniel Auclair Bridging the Cancer Gaps Title: Senior VP, Research Company: Multiple Myeloma Research Foundation Education: BS, Biochemistry, MSc, Biochemistry, University of Montreal; PhD, Nutrition/Biochemistry, Dana-Farber Cancer Institute/Harvard Cancer Center Family: Father — lost to an ...

    By PharmaVoice Team • Aug. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Technologists

    Steve Powell Tackling Technology Innovation with a Patient-Focus Title: Executive VP of Trial Oversight Company: ERT Education: BSc (Hons),  Mathematics, University of Wales, Cardiff Family: Lori, his wife who supports him in the career decisions and the changes he makes; Betty and Eddie, his mot...

    By PharmaVoice Team • Aug. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Red Jacket Awards

    2017 Red Jacket Honorees PharmaVOICE introduced the Red Jacket Award in 2014 to celebrate the 10th anniversary of the PharmaVOICE 100. One of the criteria for being named a Red Jacket — our version of a Hall of Fame — is having been recognized previously as a PharmaVOICE 100 honoree, but it’s muc...

    By PharmaVoice Team • Aug. 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Regenerative Medicine Research Tackles Hearing Loss Chris Loose, Ph.D., Co-founder and Chief Scientific Officer at Frequency Therapeutics, talks about his company’s efforts to develop a small molecule therapy to restore hearing. Hearing loss is usually the result of inner ear or nerve damage. Agi...

    By Chris Loose • June 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    J&J Company Buys 3D Printing Technology to Create Bone-healing Implants Trend Watch: Pharma, academia, and health techs employ innovation to improve patient care. DePuy Synthes Products, part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Reg...

    By PharmaVoice Team • June 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Clinical Trials Technology Ecosystem

    Data are — and will continue to be — the linchpin for clinical trials. In the future, fewer data points will come from the traditional investigator-led EDC data entry process. Emerging technologies offer an incredible potential in transforming drug development. The ability to pool real-world data...

    By PharmaVoice Team • June 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    City Centers of Excellence

    There is no disputing that the top two centers of R&D excellence in the country are San Francisco and Cambridge, Mass. However, there is much friendly debate between the two locations on which hub actually takes first place. While Bloomberg Business recently ranked Massachusetts No. 1 for inn...

    By Robin Robinson • June 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Malaria Research Update

    Despite the successful deployment of multiple interventions against malaria, there were an estimated 212 million cases of malaria and an estimated 429,000 malaria deaths worldwide in 2015, according to the most recent figures from the World Health Organization. Malaria is a mosquito-borne disease...

    By Denise Myshko • June 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE FEATURE: Clinical Trial Solutions: Redefining the Clinical Trial Solution Landscape

    Clinical trial solutions bring together technology, product, and services to automate and better manage the clinical trial process. In addition to helping to reduce time and cost, clinical trial solutions are also vital for improving data management and in integrating data from different trials f...

    By PharmaVoice Team • June 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Moving Down the Digital Path: The Next Evolution in Clinical Trials Testing

    The continued emergence of personalized medicine alongside the need for more consistent and less variable tissue analysis and interpretation has led to an increased reliance on central laboratories to perform anatomic pathology testing and services in support of clinical studies. This demand, cou...

    By Robert A. Carlson • June 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Responding to Increased FDA Focus on Data Integrity

    As clinical trials grow in complexity and new technologies emerge for capturing clinical data, the need to improve sustainability of data integrity throughout study conduct has heightened. Over the past five years, the volume of data integrity-related CGMP violations have grown in prevalence. In ...

    By Don Zinn • June 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Can CRA Empowerment Make Clinical Trials More Successful?

    A high clinical research associate (CRA) turnover rate — exceeding 25% annually — coupled with an often checklist-driven monitoring style can lead to a toxic environment for site staff. This impersonal atmosphere can lead to a negative feedback loop, in which CRAs become disengaged with the job a...

    By John Boland • June 1, 2017